{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:43:36Z","timestamp":1648575816990},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00106-020-00927-9","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T16:03:59Z","timestamp":1599149039000},"page":"140-145","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differenzialdiagnostik der Hypersomnie in der operativen Schlafmedizin \u2013 mehr als nur Schlafapnoe!"],"prefix":"10.1007","volume":"69","author":[{"given":"B. A.","family":"Stuck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. G.","family":"Wee\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Viniol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Cassel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Birk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"key":"927_CR1","volume-title":"Hypersomnie, Narkolepsie und Tagesm\u00fcdigkeit","author":"P Geisler","year":"2009","unstructured":"Geisler\u00a0P (2009) Hypersomnie, Narkolepsie und Tagesm\u00fcdigkeit. UNI-MED, Bremen"},{"key":"927_CR2","series-title":"Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie","volume-title":"S1-Leitlinie \u201eNarkolepsie\u201c, Stand: September 2012, g\u00fcltig bis: Dezember 2017","author":"C Gerloff","year":"2012","unstructured":"Gerloff\u00a0C (2012) S1-Leitlinie \u201eNarkolepsie\u201c, Stand: September 2012, g\u00fcltig bis: Dezember 2017. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Deutsche Gesellschaft f\u00fcr Neurologie (DGN), Berlin"},{"key":"927_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns\u00a0MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540\u2013545","journal-title":"Sleep"},{"issue":"1","key":"927_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/sleep\/28.1.113","volume":"28","author":"MR Littner","year":"2005","unstructured":"Littner\u00a0MR, Kushida\u00a0C, Wise\u00a0M et\u00a0al (2005) Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. An American Academy of Sleep Medicine report. AASM practice parameters. Sleep 28(1):113\u2013121","journal-title":"Sleep"},{"key":"927_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s15016-016-5546-z","volume":"27","author":"G Mayer","year":"2016","unstructured":"Mayer\u00a0G (2016) Neues von Diagnostik, Pathogenese und Therapie der Narkolepsie. Neurotransmitter 27:24\u201328","journal-title":"Neurotransmitter"},{"key":"927_CR6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1055\/s-2006-958727","volume-title":"Narkolepsie \u2013 Neue Chancen in Diagnostik & Therapie","author":"G Mayer","year":"2007","unstructured":"Mayer\u00a0G, Pollm\u00e4chter\u00a0T (2007) Narkolepsie \u2013 Neue Chancen in Diagnostik & Therapie. Thieme, Stuttgart, S\u00a016\u201327"},{"key":"927_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.neuropharm.2012.07.009","volume":"64","author":"U M\u00fcller","year":"2013","unstructured":"M\u00fcller\u00a0U, Rowe\u00a0J, Rittman\u00a0T et al (2013) Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology 64:490\u2013495","journal-title":"Neuropharmacology"},{"key":"927_CR8","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia\u00a0MJ (2014) International classification of sleep disorders. Chest 146:1387\u20131394","journal-title":"Chest"},{"key":"927_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1517\/14728214.2015.1115480","volume":"20","author":"SS Sullivan","year":"2015","unstructured":"Sullivan\u00a0SS, Guilleminault\u00a0C (2015) Emerging drugs for common conditions of sleepiness: obstructive sleep apnea and narcolepsy. Expert Opin Emerg Drugs 20:571\u2013582","journal-title":"Expert Opin Emerg Drugs"},{"key":"927_CR10","first-page":"418","volume":"34","author":"H Wee\u00df","year":"2016","unstructured":"Wee\u00df\u00a0H (2016) Die seltene Erkrankung Narkolepsie. Pitolisant aus Expertensicht. Arzneimitteltherapie 34:418\u2013420","journal-title":"Arzneimitteltherapie"},{"key":"927_CR11","volume-title":"Praxis der Schlafmedizin: Diagnostik, Differenzialdiagnostik und Therapie bei Erwachsenen und Kindern","author":"BA Stuck","year":"2017","unstructured":"Stuck\u00a0BA, Maurer\u00a0JT, Schlarb\u00a0AA et\u00a0al (2017) Praxis der Schlafmedizin: Diagnostik, Differenzialdiagnostik und Therapie bei Erwachsenen und Kindern. Springer, Berlin"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-020-00927-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-020-00927-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-020-00927-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:03:44Z","timestamp":1630706624000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-020-00927-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["927"],"URL":"https:\/\/doi.org\/10.1007\/s00106-020-00927-9","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"3 September 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"B.\u00a0A.\u00a0Stuck hat finanzielle Unterst\u00fctzung f\u00fcr Forschungsarbeiten, Berater- und Referentenhonorare und\/oder finanzielle Unterst\u00fctzung von Veranstaltungen von folgenden Firmen erhalten: Sutter Medizintechnik, Neuwirth Medical Products, Itamar Medical, Inspire Medical und L\u00f6wenstein Medical. H.\u00a0G.\u00a0Wee\u00df hat finanzielle Unterst\u00fctzung f\u00fcr die Durchf\u00fchrung von Fortbildungsveranstaltungen erhalten von UCB. W.\u00a0Cassel hat Referenten- und Beraterhonorare von folgenden Firmen erhalten: Medice Pharma P\u00fctter, Vanda Pharmaceuticals Germany, Amgen. C.\u00a0Viniol und R.\u00a0Birk geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}